Spots Global Cancer Trial Database for PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology
Official Title: A Phase I, Single-centre, Open Label, Within-subject Comparison Trial to Explore the Biological Effects of PEP005 (Ingenol Mebutate) Gel, 0.05%, Applied Once Daily for 2 Consecutive Days in Patients With Actinic Keratosis on the Upper Extremity
Study ID: NCT01387711
Conditions
Interventions
Study Description
Brief Summary: This trial will be conducted to explore the biological effects in the skin following treatment with PEP005 Gel, 0.05% administered for two consecutive days, assessed by histology.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Universitätsmedizin Göttingen, Georg-August-Universität, Göttingen, , Germany
Contact Details
Name: Michael P Schön, MD
Affiliation: Universitätsmedizin Göttingen, Georg-August-Universität
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
